Follow
Dag Nyholm
Dag Nyholm
Verified email at neuro.uu.se
Title
Cited by
Cited by
Year
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
D Nyholm, AIM Nilsson Remahl, N Dizdar, R Constantinescu, B Holmberg, ...
Neurology 64 (2), 216-223, 2005
5292005
Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets
D Nyholm, H Askmark, C Gomes–Trolin, T Knutson, H Lennernäs, ...
Clinical neuropharmacology 26 (3), 156-163, 2003
2942003
Duodenal levodopa infusion in Parkinson's disease–long‐term experience
D Nilsson, D Nyholm, SM Aquilonius
Acta Neurologica Scandinavica 104 (6), 343-348, 2001
2242001
Pharmacokinetic optimisation in the treatment of Parkinson¢s disease: an update
D Nyholm
Clinical pharmacokinetics 45, 109-136, 2006
2112006
Selecting deep brain stimulation or infusion therapies in advanced Parkinson¢s disease: an evidence-based review
J Volkmann, A Albanese, A Antonini, KR Chaudhuri, CE Clarke, ...
Journal of neurology 260, 2701-2714, 2013
1672013
Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure
D Nyholm, T Lewander, A Johansson, PA LeWitt, C Lundqvist, ...
Clinical neuropharmacology 31 (2), 63-73, 2008
1602008
Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson¢s disease
D Nyholm
Expert review of neurotherapeutics 6 (10), 1403-1411, 2006
1282006
Duodopa® treatment for advanced Parkinson's disease: a review of efficacy and safety
D Nyholm
Parkinsonism & related disorders 18 (8), 916-929, 2012
1232012
Levodopa–carbidopa intestinal gel in patients with Parkinson¢s disease: a systematic review
K Wirdefeldt, P Odin, D Nyholm
CNS drugs 30, 381-404, 2016
1132016
Irregular gastrointestinal drug absorption in Parkinson's disease
D Nyholm, H Lennernäs
Expert opinion on drug metabolism & toxicology 4 (2), 193-203, 2008
1112008
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson …
D Nyholm, P Odin, A Johansson, K Chatamra, C Locke, S Dutta, ...
The AAPS journal 15, 316-323, 2013
1092013
Levodopa/carbidopa intestinal gel infusion long‐term therapy in advanced Parkinson¢s disease
D Nyholm, K Klangemo, A Johansson
European Journal of Neurology 19 (8), 1079-1085, 2012
1082012
Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations
D Nyholm, H Lennernäs, C Gomes–Trolin, SM Aquilonius
Clinical neuropharmacology 25 (2), 89-96, 2002
1042002
A new computer method for assessing drawing impairment in Parkinson's disease
J Westin, S Ghiamati, M Memedi, D Nyholm, A Johansson, M Dougherty, ...
Journal of neuroscience methods 190 (1), 143-148, 2010
932010
Levodopa‐entacapone‐carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
M Senek, EI Nielsen, D Nyholm
Movement Disorders 32 (2), 283-286, 2017
912017
Irreversible motor impairment in young addicts–ephedrone, manganism or both?
K Sikk, P Taba, S Haldre, J Bergquist, D Nyholm, G Zjablov, T Asser, ...
Acta Neurologica Scandinavica 115 (6), 385-389, 2007
892007
Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial
D Nyholm, A Johansson, H Lennernäs, H Askmark
European Journal of Neurology 19 (6), 820-826, 2012
872012
Levodopa infusion therapy in Parkinson disease: state of the art in 2004
D Nyholm, SM Aquilonius
Clinical neuropharmacology 27 (5), 245-256, 2004
852004
New developments in levodopa therapy
PA LeWitt, D Nyholm
Neurology 62 (1_suppl_1), S9-S16, 2004
842004
An automatic dose dispenser for microtablets—a new concept for individual dosage of drugs in tablet form
S Bredenberg, D Nyholm, SM Aquilonius, C Nyström
International journal of pharmaceutics 261 (1-2), 137-146, 2003
782003
The system can't perform the operation now. Try again later.
Articles 1–20